Transforming Digital Pathology & AI: The Path Forward - Edinburgh

8th May 2024 - Royal College of Physicians of Edinburgh, Scotland

This event will sell out, please register early to ensure you don’t miss out.

Confirmed Speakers and Panelists:

Previous Speakers:

Event Overview

We are delighted to be back in Edinburgh for the 5th edition of our Transforming Digital Pathology and AI series.

This in person event will aim to discuss, debate and decipher the use of Digital Pathology in clinical settings and the successful implementation of AI aided diagnostics.

Bringing together, industry leading experts, academics and pioneering technology providers this event is an essential gathering for those at the forefront of Digital Pathology development, those just beginning and those yet to start!

With the healthcare industry’s shift towards digital solutions, Digital Pathology and AI have become pivotal in enabling detailed and quantitative pathological evaluations, like whole slide imaging and AI-based analyses. These technologies have allowed us to streamline day to day workflows and explore and extract information beyond human visual perception.

However, there are several difficulties encountered in the practical use of AI in clinical diagnosis. These include the lack of sufficient annotated data for the development and validation of AI systems, the difficulty in defining ground truth data for training and validation as well as the time and financial expense of adoption.

This event is designed to tackle the above challenges head-on. We want to create a space where you can exchange ideas, learn from others’ experiences, and gain actionable insights through real conversations.

Come and be part of a community ready to take on the future of pathology together!

Presentation titles include:

“The emerging role of artificial intelligence in pathology diagnostics: A pathologist’s perspective”.

“Computational pathology in routine clinicalreporting”.

“The NHS AI Roadmap and what it means for the NHS Long Term Workforce Plan.”

“Pathology Digitisation: Adding the human value.”

“Panel Discussion: AI in Pathology: Bridging the Gap Between Promise and Practice”.

What to expect

Case studies and presentations from the experts on applications of AI in digital pathology
8 CPD Points
Live interaction with senior speakers
Panel discussions
Exhibition
Agenda geared towards networking and close collaboration
1-2-1 Partnering Meetings
Keynote across a sit down breakfast
Hands-on product/software demos from the industry’s leading tech providers
Evening drinks reception and canapés

We look forward to welcoming you in Scotland!

Check out our hugely successful past events below.

3 for 2 offer available*

* Automatically applied at checkout, cannot be used in conjunction with any other discount.

PHD Student - £75

Access to all agenda sessions
CPD Accredited
Networking Breakfast, complimentary lunch and refreshments
Drinks reception and canapés
1-2-1 meetings with selected solution providers and peers
In-Person event exclusive content such as panel discussions and roundtables
Take home workbooks
Discounted hotel rates
Group rates (Please get in touch if booking for 5+ attendees)

Academic / NHS / Not for Profit - £129

Access to all agenda sessions
CPD Accredited
Networking Breakfast, complimentary lunch and refreshments
Drinks reception and canapés
1-2-1 meetings with selected solution providers and peers
In-Person event exclusive content such as panel discussions and roundtables
Take home workbooks
Discounted hotel rates
Group rates (Please get in touch if booking for 5+ attendees)

Industry / Pharmaceutical - £299

Access to all agenda sessions
CPD Accredited
Networking Breakfast, complimentary lunch and refreshments
Drinks reception and canapés
1-2-1 meetings with selected solution providers and peers
In-Person event exclusive content such as panel discussions and roundtables
Take home workbooks
Discounted hotel rates
Group rates (Please get in touch if booking for 5+ attendees)

Service / Solution Provider - £699

Access to all agenda sessions
CPD Accredited
Networking Breakfast, complimentary lunch and refreshments
Drinks reception and canapés
1-2-1 meetings with selected solution providers and peers
In-Person event exclusive content such as panel discussions and roundtables
Take home workbooks
Discounted hotel rates
Group rates (Please get in touch if booking for 5+ attendees)

Technology Partners & Exhibitors:

Aiforia equips pathologists and scientists in preclinical, academic, and clinical labs with the most powerful deep learning artificial intelligence and cloud-based technology to increase the speed, accuracy, and consistency of analyzing large and complex medical images across a variety of fields from oncology to neuroscience.

Aiforia is composed of an ideal mix of scientists experienced in a variety of medical areas from pathology to cancer diagnostics, software developers who collectively hold over 100 years’ experience in artificial intelligence, and a business team with backgrounds in the pharmaceutical and biotechnology industries.

Founded by Dr Martin Fergie, Dr Richard Byers and Dr Anna Maria Tsakiroglou. Spotlight Pathology develop artificial intelligence tools to support the diagnosis of blood cancers.

AIRA Matrix provides Artificial Intelligence solutions for Life Sciences applications. Our products and services improve efficiency, diagnostic accuracy, and turnaround times in pathology laboratory workflows. Our diagnostic, prognostic, and predictive solutions for cancer care aid disease stratification and enable management protocols tailored to improve treatment outcomes. Our clients and partners include leading hospitals, pharmaceutical companies, CROs, and research labs around the world.

Since 2016, Ibex has led the way in AI-powered diagnostics for pathology. We set out to transform pathology by ensuring that every patient can receive an accurate, timely and personalized cancer diagnosis.

Today, we are the most widely-deployed artificial intelligence platform in pathology. Developed by pathologists for pathologists, our solutions serve the world’s leading physicians, healthcare organizations and diagnostic providers.

Every day, we have the privilege of touching the lives of patients worldwide. We raise physician confidence, streamline diagnostic workflows, help clinicians provide more personalized diagnosis and, most importantly, enable better clinical outcomes.

Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner.

We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from siloed datasets while protecting patient privacy and securing proprietary data.

Owkin was co-founded by Thomas Clozel MD, a former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016. Owkin has raised over $300 million and became a unicorn through investments from leading biopharma companies (Sanofi and BMS) and venture funds (Fidelity, GV and BPI, among others).

Led by a team of experts in the fields of life sciences, oncology, pathology, technology, machine learning, and healthcare, Paige strives to transform cancer diagnostics.

We make it possible not only to provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and confidently, but also to go beyond by extracting novel insights from digital slides that can’t be seen by the naked eye.

These unique tissue signatures have the potential to help guide treatment decisions and enable the development of novel biomarkers from tissues for diagnostic, pharmaceutical and life sciences companies.

Source LDPath, a part of Source BioScience, helps pathology labs go digital with its ground-breaking modular digital pathology and AI pathway which helps transform diagnostic processes by drastically decreasing turnaround times from sample receipt to result, to help patients access appropriate treatment as quickly as possible.

We are your guiding hand in digital pathology and AI integration.

Leica Biosystems (LeicaBiosystems.com) is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis.

With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our experts are committed to delivering Improved Quality, Integrated Solutions, and Optimized Efficiencies leading to breakthrough advances in diagnostic confidence.

Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Leica Biosystems is headquartered in Germany and operates in over 100 countries.